Literature DB >> 6848134

Compliance with treatment of patients with chronic open-angle glaucoma.

J M MacKean, A R Elkington.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6848134      PMCID： PMC1039944          DOI： 10.1136/bjo.67.1.46

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

1.  Patients' viewpoint of glaucoma therapy.

Authors:  P A Vincent
Journal:  Sight Sav Rev       Date:  1972

2.  Visual loss in a glaucoma clinic. I. Sociological considerations.

Authors:  G L Spaeth
Journal:  Invest Ophthalmol       Date:  1970-01

3.  Compliance in ophthalmology.

Authors:  S I Davidson; T Akingbehin
Journal:  Trans Ophthalmol Soc U K       Date:  1980-07

4.  Monitoring compliance with pilocarpine therapy.

Authors:  S E Norell
Journal:  Am J Ophthalmol       Date:  1981-11       Impact factor: 5.258

5.  Self-medication with pilocarpine among outpatients in a glaucoma clinic.

Authors:  S E Norell; P A Granström
Journal:  Br J Ophthalmol       Date:  1980-02       Impact factor: 4.638

6.  Patient compliance in glaucoma.

Authors:  S Bloch; A R Rosenthal; L Friedman; P Caldarolla
Journal:  Br J Ophthalmol       Date:  1977-08       Impact factor: 4.638

7.  Memory for medical information.

Authors:  P Ley
Journal:  Br J Soc Clin Psychol       Date:  1979-06
  7 in total
  17 in total

1.  The influence of health literacy level on an educational intervention to improve glaucoma medication adherence.

Authors:  Kelly W Muir; Alice Ventura; Sandra S Stinnett; Abraham Enfiedjian; R Rand Allingham; Paul P Lee
Journal:  Patient Educ Couns       Date:  2011-10-13

2.  Compliance: clear communication's critical.

Authors:  A J Buller; B Connell; A F Spencer
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

3.  Microprocessor controlled compliance monitor for eye drop medication.

Authors:  M M Hermann; M Diestelhorst
Journal:  Br J Ophthalmol       Date:  2006-03-15       Impact factor: 4.638

4.  Topical beta blockers and serum lipoproteins.

Authors:  P W Joyce; P S Raj
Journal:  Br J Ophthalmol       Date:  1991-08       Impact factor: 4.638

5.  Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.

Authors:  Christine M G Olthoff; Juliette G M M Hoevenaars; Bart W van den Borne; Carroll A B Webers; Jan S A G Schouten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-19       Impact factor: 3.117

6.  Glaucoma severity and medication adherence in a county hospital population.

Authors:  Cindy Ung; Elisa Zhang; Tatyana Alfaro; Yohko Murakami; Monica Zhang; Michael I Seider; Shan C Lin; Kuldev Singh
Journal:  Ophthalmology       Date:  2013-02-28       Impact factor: 12.079

7.  Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.

Authors:  Myoung Hee Park; Kyu-Dong Kang; Jungil Moon
Journal:  Jpn J Ophthalmol       Date:  2012-10-12       Impact factor: 2.447

8.  Glaucoma patients' trust in the physician.

Authors:  Kelly W Muir; Cecilia Santiago-Turla; Sandra S Stinnett; Leon W Herndon; R Rand Allingham; Pratap Challa; Paul P Lee
Journal:  J Ophthalmol       Date:  2009-10-07       Impact factor: 1.909

9.  The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies.

Authors:  Allan J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2008

10.  Extended release of timolol from nanoparticle-loaded fornix insert for glaucoma therapy.

Authors:  Hyun Jung Jung; Anuj Chauhan
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-03       Impact factor: 2.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.